Intelligence Β· Clinical Pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
- Programs
- 4,713
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
-
EXPAREL
Pacira Ireland Limited
Healthy
1 trial -
EXPAREL
Pacira Ireland Limited
Healthy Volunteers
1 trial -
EXS73565
RECURSION PHARMACEUTICALS, INC.
Relapsed or Refractory B-cell Malignancies
1 trial -
EXS74539
RECURSION PHARMACEUTICALS, INC.
Solid Tumor
1 trial -
EXT608
Universal Integrated
Safety Issues
1 trial -
Ebola Vaccine - low dose
United Therapeutics Europe Ltd
Ebola Virus Disease
1 trial -
Effect of Erythromycin on the absorption, metabolism and elimination of CHF6001 in healthy volunteers
Chiesi Farmaceutici S.p.A
This study is a phase I trial to investigate the effect of inhibition of CYP3A4/5 by Erythromycin on the pharmacokinetics of CHF6001 in healthy volunteers.
1 trial -
Effect of NBI-921355 on corticospinal excitability in healthy participants
NEUROCRINE BIOSCIENCES INC
Epilepsy
1 trial -
Effect of Renal Impairment on Enpatoran Pharmacokinetics
Merck Sharp and Dohme
Healthy volunteers and patients with renal impairment; Intended indication: autoimmune diseases; systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE), as well as dermatomyositis (DM) and polymyositis (PM).
1 trial -
Effect of SAR445611 on inflammatory responses following LPS challenge study in healthy participants
Sanofi-aventis Healthcare Pty Ltd
Immune system diseases
1 trial -
Efficacy of LCAR-T2C CAR-T cells
Nanjing Legend Biotech Co.
CD4+ T Lymphocyte Tumor (T Cell Lymphoma and T Cell Leukemia)
1 trial -
Efficacy of LCAR-T2C CAR-T cells
Nanjing Legend Biotech Co.
T Cell Lymphoma
1 trial -
Elagolix
NEUROCRINE BIOSCIENCES INC
Folliculogenesis
1 trial -
Electroporation-Mediated Plasmid DNA Vaccine Therapy
INOVIO PHARMACEUTICALS, INC.
Chronic Hepatitis
1 trial -
Elimusertib (BAY1895344)
Bayer HealthCare AG
Advanced Solid Tumor
1 trial -
Eltanexor
Karyopharm Therapeutics Inc
Relapsed Myelodysplastic Syndrome
1 trial -
Empagliflozin 10 MG Oral Tablet [Jardiance]
BRIGHT MINDS BIOSCIENCES INC.
Diabetes Mellitus
1 trial -
Emtricitabine
United Therapeutics Europe Ltd
HIV
1 trial -
Encapsulated Calcium
United Therapeutics Europe Ltd
Pregnancy
1 trial -
Endo Tool
United Therapeutics Europe Ltd
Burns
1 trial -
Engineered mitochondrial vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Advanced Solid Tumor Malignancies
1 trial -
Entinostat
Syndax Pharmaceuticals
Neoplasms
2 trials -
Entinostat
Syndax Pharmaceuticals
Volunteers
2 trials -
Entinostat
Syndax Pharmaceuticals
Pancreas Cancer
1 trial -
Entinostat
Syndax Pharmaceuticals
Renal Impairment
1 trial -
Entinostat
Syndax Pharmaceuticals
Metastatic Breast Cancer
1 trial -
Entinostat
Syndax Pharmaceuticals
Fallopian Tube Cancer
1 trial -
Entinostat
Syndax Pharmaceuticals
Drug Interaction
1 trial -
Enzalutamide
CORCEPT THERAPEUTICS INC
Prostate Cancer
1 trial -
Epetraborole
AN2 Therapeutics
Renal Insufficiency
1 trial -
Epetraborole
AN2 Therapeutics
Healthy Volunteers
1 trial -
Epetraborole and matching placebo
AN2 Therapeutics
Healthy Volunteers
1 trial -
Epidiolex
BRIGHT MINDS BIOSCIENCES INC.
CBD
1 trial -
Epidiolex 100 mg/mL Oral Solution
Jazz Pharmaceuticals Ireland Limited
Electrical Status Epilepticus of Slow-Wave Sleep
1 trial -
Eplontersen
IONIS PHARMACEUTICALS INC
Healthy Participants
1 trial -
Eprolidone
The First People's Hospital of Lianyungang
Chronic Heart Failure Patients
1 trial -
Erwinase
Jazz Pharmaceuticals Ireland Limited
Acute Lymphoblastic Leukemia
1 trial -
Erwinia Chrysanthemi asparaginase
Jazz Pharmaceuticals Ireland Limited
Acute Lymphoblastic Leukemia (ALL)
1 trial -
EryDex (dexamethasone sodium phosphate encapsulated erythrocytes)
Quince Therapeutics
Healthy
1 trial -
Erythromycin lactobionate
ADIAL PHARMACEUTICALS, INC.
Diabetes Mellitus, Type 1
1 trial -
Escitalopram
Universal Integrated
Major Depressive Disorder
1 trial -
Esketamine injection group (0.25 mg/kg)
The First People's Hospital of Lianyungang
Esketamine
1 trial -
Esomeprazole Capsule
Takeda
Healthy Participants
1 trial -
Estradiol/Norethindrone acetate
Teva Pharma GmbH
Healthy
2 trials -
Etanercept
United Therapeutics Europe Ltd
Gulf War Illness
1 trial -
Ethinyl Estradioll/Levonorgestrel (EE/LNG)
Atea Pharmaceuticals
Healthy Volunteer Study
1 trial -
Etrasimod Arginine Blue
Pfizer Australia Pty Ltd
Ulcerative Colitis and immune-mediated inflammatory disorders
1 trial -
Etripamil Nasal Spray 70mg
Milestone Pharmaceuticals
Healthy Chinese Subjects
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources Β· All pipeline programs